Toxicities and Deaths From Intercurrent Disease Following Contemporary Postoperative Radiotherapy in Resected Non-Small-Cell Lung Cancer
CONCLUSION: PORT using contemporary techniques was well tolerated with acceptable toxicity and low rates of intercurrent deaths. Proton therapy significantly reduced heart and lung doses, but radiotherapy modality was not associated with differences in intercurrent disease.PMID:36628846 | DOI:10.1016/j.cllc.2022.12.008
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Kristine N Kim Jonathan Heintz Nikhil Yegya-Raman Roger Cohen Timothy Kegelman Keith Cengel Melina Marmarelis Lova Sun Corey Langer Charu Aggarwal Aditi Singh Sunil Singhal John Kucharczuk Kyle Robinson Steven Feigenberg Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Heart | Lung Cancer | Non-Small Cell Lung Cancer | Proton Therapy | Study | Toxicology